Related Links
Current Releases
Stock Quote
Standard & Poor's
SEC Filings
Mailing List
Releases Archives
Opexa Therapeutics Headlines
11/01/2005 - 05:04 PM
PharmaFrontiers Corp. Reconstitutes Its Audit Committee
10/31/2005 - 04:00 AM
PharmaFrontiers Tovaxin(TM) Phase IIb Multiple Sclerosis Clinical Trial Protocol Accepted by FDA
10/26/2005 - 04:27 PM
PharmaFrontiers Corp. Elects Interim Chairman
10/25/2005 - 08:39 AM
PharmaFrontiers Corp. to Present at the PIPEs Conference 2005
10/18/2005 - 08:57 AM
PharmaFrontiers Corp. Names Brooks Boveroux to Board of Directors
10/17/2005 - 09:15 AM
PharmaFrontiers Corp. to Present at the 2005 BIO Emerging Company Investor Forum
10/03/2005 - 05:00 AM
PharmaFrontiers Presents Positive Tovaxin(TM) Research at International Multiple Sclerosis Meeting
09/22/2005 - 01:05 PM
PharmaFrontiers Cancels Presentation Due to Hurricane Rita
09/21/2005 - 09:59 AM
PharmaFrontiers to Present at Sanders Morris Harris Growth Conference
09/13/2005 - 11:33 AM
PharmaFrontiers to Present at ValueRich Small Cap Financial Exposition
08/16/2005 - 12:17 PM
PharmaFrontiers Reports Second Quarter 2005 Financial Results; Provides Research Update
08/10/2005 - 04:00 AM
PharmaFrontiers to Present Tovaxin(TM) Research at International Multiple Sclerosis Meeting
07/27/2005 - 03:00 PM
PharmaFrontiers Plans to Ask SEC for Accelerated Effective Date
06/20/2005 - 06:00 AM
PharmaFrontiers Completes $5.08 MM Financing
06/08/2005 - 04:00 AM
PharmaFrontiers Presented Preliminary Tovaxin Clinical Plans at Multiple Sclerosis Centers Meeting
06/03/2005 - 05:00 AM
PharmaFrontiers Announces Positive Interim Results of Two Phase I/II Clinical Trials for Multiple Sclerosis
05/17/2005 - 04:00 AM
PharmaFrontiers Adds Three Members to Its Scientific Advisory Board
05/03/2005 - 06:00 AM
PharmaFrontiers Selects INC Research as Development Partner for its Novel Multiple Sclerosis Therapy
04/26/2005 - 04:00 AM
PharmaFrontiers Announces Dr. Eliezer Huberman to Chair Scientific Advisory Board
04/15/2005 - 04:00 AM
PharmaFrontiers Provides Update, Financial Results
1
2
3
4
5
« Previous
Releases Archives
